Naltrexone & SSRI in Alcoholics With Depression/PTSD

Completed · Phase 3 · Has a placebo group

Conditions studied: Alcoholism, Depression, PTSD

In brief

The purpose of this study is to evaluate the efficacy of naltrexone in combination with an SSRI to reduce alcohol consumption in alcoholic patients with comorbid PTSD and depression. We hypothesize that the combination of naltrexone and SSRI will exhibit a greater decrease in alcohol consumption than that seen with treatment with SSRI alone, or with a combination of another class of antidepressant and naltrexone. We also hypothesize that SSRI will be effective in treating PTSD and depressive symptoms and naltrexone will be well tolerated.

Key facts

Study ID
NCT00338962
Run by
Yale University
People needed
88
Starts
2001-10-01
Expected to finish
2015-07-01
Last updated by the study team
2016-02-05

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.